Introduction
This briefing paper describes some of the practical and legal obstacles facing Member States when responding to such new substances. It underlines the importance of national early-warning systems in detecting and identifying new substances as the first step towards assessing the risks of, and ultimately controlling, potentially dangerous new drugs.
Download as PDF
- Bulgarian (bg)
- Czech (cs)
- Danish (da)
- Dutch (nl)
- Dutch (nl)
- English (en)
- English (en)
- Estonian (et)
- Finnish (fi)
- French (fr)
- German (de)
- Greek (el)
- Hungarian (hu)
- Irish (ga)
- Italian (it)
- Latvian (lv)
- Maltese (mt)
- Norwegian (no)
- Polish (pl)
- Romanian (ro)
- Slovakian (sk)
- Slovene (sl)
- Spanish (es)
- Swedish (sv)
- Turkish (tr)
Table of contents
- Definitions
- Key issues at a glance
- Early-warning systems
- Proactive control
- Assessing the risks
- Faster processes — but supervised
- Unintended consequences of control
- Are other laws effective?
- Conclusions and policy considerations
- Key sources
- Web information